BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 25316606)

  • 1. Sjögren Syndrome-associated lymphomas: an update on pathogenesis and management.
    Nocturne G; Mariette X
    Br J Haematol; 2015 Feb; 168(3):317-27. PubMed ID: 25316606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Protein A20 in Minor Salivary Glands is Associated with Lymphoma in Primary Sjögren's Syndrome.
    Johnsen SJ; Gudlaugsson E; Skaland I; Janssen EA; Jonsson MV; Helgeland L; Berget E; Jonsson R; Omdal R
    Scand J Immunol; 2016 Mar; 83(3):181-7. PubMed ID: 26679293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosa-associated lymphoid tissue lymphoma in Sjögren's syndrome: risks, management, and prognosis.
    Voulgarelis M; Moutsopoulos HM
    Rheum Dis Clin North Am; 2008 Nov; 34(4):921-33, viii. PubMed ID: 18984412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic markers of lymphoma development in primary Sjögren syndrome.
    Retamozo S; Brito-Zerón P; Ramos-Casals M
    Lupus; 2019 Jul; 28(8):923-936. PubMed ID: 31215845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells.
    Mariette X
    Ann Rheum Dis; 2001 Nov; 60(11):1007-10. PubMed ID: 11602464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gougerot-Sjögren syndrome. Risk of lymphoma].
    Mariette X
    Presse Med; 1999 Jun; 28(22):1214-8. PubMed ID: 10414252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid disease in Sjögren's syndrome.
    Jara LJ; Navarro C; Brito-Zerón Mdel P; García-Carrasco M; Escárcega RO; Ramos-Casals M
    Clin Rheumatol; 2007 Oct; 26(10):1601-6. PubMed ID: 17558463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The relationship between Sjogren's syndrome, systemic sclerosis and lymphoproliferative diseases].
    Vasil'ev VI; Chal'tsev BD; Gorodetskii VR; Pal'shina SG; Shornikova NS; Anan'eva LP; Gaiduk IV; Kokosadze NV; Probatova NA; Pavlovskaia AI; Rodionova EB; Safonova TN; Balabina AA
    Ter Arkh; 2020 Dec; 92(12):126-136. PubMed ID: 33720584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren's syndrome.
    Nezos A; Papageorgiou A; Fragoulis G; Ioakeimidis D; Koutsilieris M; Tzioufas AG; Moutsopoulos HM; Voulgarelis M; Mavragani CP
    J Autoimmun; 2014 Jun; 51():89-98. PubMed ID: 23845207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphomas in patients with Sjögren's syndrome: review of the literature and physiopathologic hypothesis.
    Mariette X
    Leuk Lymphoma; 1999 Mar; 33(1-2):93-9. PubMed ID: 10194125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection.
    Ramos-Casals M; la Civita L; de Vita S; Solans R; Luppi M; Medina F; Caramaschi P; Fadda P; de Marchi G; Lopez-Guillermo A; Font J;
    Arthritis Rheum; 2007 Feb; 57(1):161-70. PubMed ID: 17266090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome.
    Solans-Laqué R; López-Hernandez A; Bosch-Gil JA; Palacios A; Campillo M; Vilardell-Tarres M
    Semin Arthritis Rheum; 2011 Dec; 41(3):415-23. PubMed ID: 21665245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MALT lymphoma of the parotid gland associated with Sjögren syndrome. A case report and review of literature].
    Damborenea Tajada J; García Erce JA; Castillo Fornies AC; Leache Pueyo J; Naya Gálvez MJ; Rubio Martínez A; Ortiz García A
    Acta Otorrinolaringol Esp; 1998 Oct; 49(7):595-8. PubMed ID: 9866230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies against a 72-kDa ductal cell membrane glycoprotein in a patient affected by Sjögren's syndrome and gastric MALT lymphoma.
    Folli F; Perego L; Ponzoni M; Girardi AM; Bosi E; Ferreri AJ; Bellone M; Sabbadini MG; Vicari AM; Trusolino L
    Ann Hematol; 2002 Oct; 81(10):597-602. PubMed ID: 12424543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant lymphoma in primary Sjögren's syndrome: an update on the pathogenesis and treatment.
    Routsias JG; Goules JD; Charalampakis G; Tzima S; Papageorgiou A; Voulgarelis M
    Semin Arthritis Rheum; 2013 Oct; 43(2):178-86. PubMed ID: 23816048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary tumours in Sjögren's syndrome.
    Kovács L; Szodoray P; Kiss E
    Autoimmun Rev; 2010 Feb; 9(4):203-6. PubMed ID: 19602455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of germinal center-like structures and B cell clonality in patients with primary Sjögren syndrome with and without lymphoma.
    Johnsen SJ; Berget E; Jonsson MV; Helgeland L; Omdal R; Jonsson R
    J Rheumatol; 2014 Nov; 41(11):2214-22. PubMed ID: 25274895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome.
    Nocturne G; Virone A; Ng WF; Le Guern V; Hachulla E; Cornec D; Daien C; Vittecoq O; Bienvenu B; Marcelli C; Wendling D; Amoura Z; Dhote R; Lavigne C; Fior R; Gottenberg JE; Seror R; Mariette X
    Arthritis Rheumatol; 2016 Apr; 68(4):977-85. PubMed ID: 26606524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosa-associated lymphoid tissue lymphoma of the salivary glands occurring in patients affected by Sjögren's syndrome: report of 6 cases.
    Biasi D; Caramaschi P; Ambrosetti A; Carletto A; Mocella S; Randon M; Bambara LM
    Acta Haematol; 2001; 105(2):83-8. PubMed ID: 11408709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sjögren's syndrome and non-Hodgkin's lymphoma: from pathophysiology to treatment].
    Le Guern V; Mouthon L
    Presse Med; 2011 Dec; 40(12 Pt 1):1113-9. PubMed ID: 21964038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.